Additional Evidence for DDB2 T338M as a Genetic Risk Factor for Ocular Squamous Cell Carcinoma in Horses
Squamous cell carcinoma (SCC) is the most common periocular cancer in horses and the second most common tumor of the horse overall. A missense mutation in damage-specific DNA-binding protein 2 (DDB2, c.1012 C>T, p.Thr338Met) was previously found to be strongly associated with ocular SCC in Haflin...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | International Journal of Genomics |
| Online Access: | http://dx.doi.org/10.1155/2019/3610965 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832568110635286528 |
|---|---|
| author | Moriel H. Singer-Berk Kelly E. Knickelbein Zachary T. Lounsberry Margo Crausaz Savanna Vig Nikhil Joshi Monica Britton Matthew L. Settles Christopher M. Reilly Ellison Bentley Catherine Nunnery Ann Dwyer Mary E. Lassaline Rebecca R. Bellone |
| author_facet | Moriel H. Singer-Berk Kelly E. Knickelbein Zachary T. Lounsberry Margo Crausaz Savanna Vig Nikhil Joshi Monica Britton Matthew L. Settles Christopher M. Reilly Ellison Bentley Catherine Nunnery Ann Dwyer Mary E. Lassaline Rebecca R. Bellone |
| author_sort | Moriel H. Singer-Berk |
| collection | DOAJ |
| description | Squamous cell carcinoma (SCC) is the most common periocular cancer in horses and the second most common tumor of the horse overall. A missense mutation in damage-specific DNA-binding protein 2 (DDB2, c.1012 C>T, p.Thr338Met) was previously found to be strongly associated with ocular SCC in Haflinger and Belgian horses, explaining 76% of cases across both breeds. To determine if this same variant in DDB2 contributes to risk for ocular SCC in the Arabian, Appaloosa, and Percheron breeds and to determine if the variant contributes to risk for oral or urogenital SCC, histologically confirmed SCC cases were genotyped for the DDB2 variant and associations were investigated. Horses with urogenital SCC that were heterozygous for the DDB2 risk allele were identified in the Appaloosa breed, but a significant association between the DDB2 variant and SCC occurring at any location in this breed was not detected. The risk allele was not identified in Arabians, and no Percherons were homozygous for the risk allele. High-throughput sequencing data from six Haflingers were analyzed to ascertain if any other variant from the previously associated 483 kb locus on ECA12 was more concordant with the SCC phenotype than the DDB2 variant. Sixty polymorphisms were prioritized for evaluation, and no other variant from this locus explained the genetic risk better than the DDB2 allele (P=3.39×10−17, n=118). These data provide further support of the DDB2 variant contributing to risk for ocular SCC, specifically in the Haflinger and Belgian breeds. |
| format | Article |
| id | doaj-art-dd6d539c36224090b471c853b10c1a59 |
| institution | Kabale University |
| issn | 2314-436X 2314-4378 |
| language | English |
| publishDate | 2019-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Genomics |
| spelling | doaj-art-dd6d539c36224090b471c853b10c1a592025-02-03T00:59:46ZengWileyInternational Journal of Genomics2314-436X2314-43782019-01-01201910.1155/2019/36109653610965Additional Evidence for DDB2 T338M as a Genetic Risk Factor for Ocular Squamous Cell Carcinoma in HorsesMoriel H. Singer-Berk0Kelly E. Knickelbein1Zachary T. Lounsberry2Margo Crausaz3Savanna Vig4Nikhil Joshi5Monica Britton6Matthew L. Settles7Christopher M. Reilly8Ellison Bentley9Catherine Nunnery10Ann Dwyer11Mary E. Lassaline12Rebecca R. Bellone13Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616, USAVeterinary Genetics Laboratory, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616, USAVeterinary Genetics Laboratory, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616, USAVeterinary Genetics Laboratory, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616, USAVeterinary Genetics Laboratory, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616, USABioinformatics Core Facility, Genome Center, University of California-Davis, Davis, CA 95616, USABioinformatics Core Facility, Genome Center, University of California-Davis, Davis, CA 95616, USABioinformatics Core Facility, Genome Center, University of California-Davis, Davis, CA 95616, USAInsight Veterinary Specialty Pathology, Davis, CA, USADepartment of Surgical Services, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53706, USASchool of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USAGenesee Valley Equine Clinic, Scottsville, NY 14546, USADepartment of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616, USAVeterinary Genetics Laboratory, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616, USASquamous cell carcinoma (SCC) is the most common periocular cancer in horses and the second most common tumor of the horse overall. A missense mutation in damage-specific DNA-binding protein 2 (DDB2, c.1012 C>T, p.Thr338Met) was previously found to be strongly associated with ocular SCC in Haflinger and Belgian horses, explaining 76% of cases across both breeds. To determine if this same variant in DDB2 contributes to risk for ocular SCC in the Arabian, Appaloosa, and Percheron breeds and to determine if the variant contributes to risk for oral or urogenital SCC, histologically confirmed SCC cases were genotyped for the DDB2 variant and associations were investigated. Horses with urogenital SCC that were heterozygous for the DDB2 risk allele were identified in the Appaloosa breed, but a significant association between the DDB2 variant and SCC occurring at any location in this breed was not detected. The risk allele was not identified in Arabians, and no Percherons were homozygous for the risk allele. High-throughput sequencing data from six Haflingers were analyzed to ascertain if any other variant from the previously associated 483 kb locus on ECA12 was more concordant with the SCC phenotype than the DDB2 variant. Sixty polymorphisms were prioritized for evaluation, and no other variant from this locus explained the genetic risk better than the DDB2 allele (P=3.39×10−17, n=118). These data provide further support of the DDB2 variant contributing to risk for ocular SCC, specifically in the Haflinger and Belgian breeds.http://dx.doi.org/10.1155/2019/3610965 |
| spellingShingle | Moriel H. Singer-Berk Kelly E. Knickelbein Zachary T. Lounsberry Margo Crausaz Savanna Vig Nikhil Joshi Monica Britton Matthew L. Settles Christopher M. Reilly Ellison Bentley Catherine Nunnery Ann Dwyer Mary E. Lassaline Rebecca R. Bellone Additional Evidence for DDB2 T338M as a Genetic Risk Factor for Ocular Squamous Cell Carcinoma in Horses International Journal of Genomics |
| title | Additional Evidence for DDB2 T338M as a Genetic Risk Factor for Ocular Squamous Cell Carcinoma in Horses |
| title_full | Additional Evidence for DDB2 T338M as a Genetic Risk Factor for Ocular Squamous Cell Carcinoma in Horses |
| title_fullStr | Additional Evidence for DDB2 T338M as a Genetic Risk Factor for Ocular Squamous Cell Carcinoma in Horses |
| title_full_unstemmed | Additional Evidence for DDB2 T338M as a Genetic Risk Factor for Ocular Squamous Cell Carcinoma in Horses |
| title_short | Additional Evidence for DDB2 T338M as a Genetic Risk Factor for Ocular Squamous Cell Carcinoma in Horses |
| title_sort | additional evidence for ddb2 t338m as a genetic risk factor for ocular squamous cell carcinoma in horses |
| url | http://dx.doi.org/10.1155/2019/3610965 |
| work_keys_str_mv | AT morielhsingerberk additionalevidenceforddb2t338masageneticriskfactorforocularsquamouscellcarcinomainhorses AT kellyeknickelbein additionalevidenceforddb2t338masageneticriskfactorforocularsquamouscellcarcinomainhorses AT zacharytlounsberry additionalevidenceforddb2t338masageneticriskfactorforocularsquamouscellcarcinomainhorses AT margocrausaz additionalevidenceforddb2t338masageneticriskfactorforocularsquamouscellcarcinomainhorses AT savannavig additionalevidenceforddb2t338masageneticriskfactorforocularsquamouscellcarcinomainhorses AT nikhiljoshi additionalevidenceforddb2t338masageneticriskfactorforocularsquamouscellcarcinomainhorses AT monicabritton additionalevidenceforddb2t338masageneticriskfactorforocularsquamouscellcarcinomainhorses AT matthewlsettles additionalevidenceforddb2t338masageneticriskfactorforocularsquamouscellcarcinomainhorses AT christophermreilly additionalevidenceforddb2t338masageneticriskfactorforocularsquamouscellcarcinomainhorses AT ellisonbentley additionalevidenceforddb2t338masageneticriskfactorforocularsquamouscellcarcinomainhorses AT catherinenunnery additionalevidenceforddb2t338masageneticriskfactorforocularsquamouscellcarcinomainhorses AT anndwyer additionalevidenceforddb2t338masageneticriskfactorforocularsquamouscellcarcinomainhorses AT maryelassaline additionalevidenceforddb2t338masageneticriskfactorforocularsquamouscellcarcinomainhorses AT rebeccarbellone additionalevidenceforddb2t338masageneticriskfactorforocularsquamouscellcarcinomainhorses |